刘若云,刘然,戴枚芳,焦玥淼,李杨,常三帅,徐野,卢志南,赵丽,阴赪茜,宋光远

• 1:北京体育大学运动人体科学学院
• 2:首都医科大学附属北京安贞医院心脏瓣膜病介入中心

摘要(Abstract)：

目的 以全生命周期管理理念为指导的智慧医疗体系在经导管主动脉瓣置换术（TAVR）后患者的长期管理中具有重要意义，旨在探讨这一管理体系在降低患者不良事件发生率、提供个体化医疗建议和改善生存预后方面的作用。方法 连续收集2021年6月至2023年8月首都医科大学附属北京安贞医院瓣膜病介入中心408例TAVR患者数据。2021年6月至2022年10月的患者为常规门诊复查组，2022年11月至2023年8月的患者为心脏监测组。通过Kaplan-Meier、Cox比例风险模型等进行分析，评估智慧医疗在术后长期管理的效果。结果 单因素Cox风险比例校正后，心脏监测组复合终点发生率显著低于常规门诊复查组（8.9%比17.7%,P=0.016）；心脏监测组患者得到医疗救助的平均时间间隔明显缩短（3.02 h比97.09 h,P<0.001）；使用心脏监测设备和智慧医疗平台对改善患者预后具有显著意义（HR0.439,95%CI 0.244～0.790,P=0.006）。结论 在现代互联网支持下，使用心脏监测设备能够有效预警TAVR术后患者的临床事件，改善术后的生存质量，为患者提供全面、持续、专业的医疗照护。

关键词(KeyWords)： 经导管主动脉瓣置换术;全生命周期管理;心脏多参数监测;远程智慧医疗

Abstract:

Keywords:

基金项目(Foundation): 北京安贞医院科创基金项目（AZ2022-CXZH-02）

作者(Author): 刘若云,刘然,戴枚芳,焦玥淼,李杨,常三帅,徐野,卢志南,赵丽,阴赪茜,宋光远

参考文献(References)：

• [1] Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease:a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines[J]. Circulation,2021,143(5):e72-e227. DOI:10.1161/CIR.0000000000000923.
• [2] Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS guidelines for the management of valvular heart disease[J]. Eur Heart J,2022,43(7):561-632. DOI:10.1093/eurheartj/ehab395.
• [3]王墨扬，周政，牛冠男，等.经导管主动脉瓣置换术2023年度进展[J].中国介入心脏病学杂志，2024,32(01):14-19.DOI:10.3969/j.issn.1004-8812.2024.01.004.
• [4]中国医师协会心血管内科医师分会结构性心脏病专业委员会.经导管主动脉瓣置换术后运动康复专家共识[J].中国介入心脏病学杂志，2020,28(7):361-368. DOI:10.3969/j.issn.1004-8812.2020.07.001.
• [5]马丽媛，王增武，樊静，等.《中国心血管健康与疾病报告2021》概要[J].中国介入心脏病学杂志，2022,30(7):481-496. DOI:10.3969/j.issn.1004-8812.2022.07.001.
• [6] Ream K, Sandhu A, Valle J, et al. Ambulatory rhythm monitoring to detect late high-grade atrioventricular block following transcatheter aortic valve replacement[J]. J Am Coll Cardiol,2019,73(20):2538-2547.DOI:10.1016/j.jacc.2019.02.068.
• [7] Muntané-Carol G, Okoh AK, Chen C, et al. Ambulatory electrocardiographic monitoring following minimalist transcatheter aortic valve replacement[J]. JACC Cardiovasc Interv,2021,14(24):2711-2722.DOI:10.1016/j.jcin.2021.08.039.
• [8] Muntané-Carol G, Philippon F, Nault I, et al. Ambulatory electrocardiogram monitoring in patients undergoing transcatheter aortic valve replacement:JACC state-of-the-art review[J].J Am Coll Cardiol,2021,77(10):1344-1356.DOI:10.1016/j.jacc.2020.12.062.
• [9]中国医师协会心血管内科医师分会结构性心脏病学组，周达新，吴永健.单纯主动脉瓣反流经股动脉主动脉瓣置换中国专家共识2023[J].中国介入心脏病学杂志，2023,31(11):801-809. DOI:10.3969/j.issn.1004-8812.2023.11.001.
• [10] Makkar RR, Blanke P, Leipsic J, et al. Subclinical leaflet thrombosis in transcatheter and surgical bioprosthetic valves:PARTNER 3cardiac computed tomography substudy[J]. J Am Coll Cardiol,2020, 75(24):3003-15. DOI:10.1016/j.jacc.2020.04.043.
• [11] Makkar RR, Thourani VH, Mack MJ, et al. Five-year outcomes of transcatheter or surgical aortic-valve replacement[J]. N Engl J Med,2020,382(9):799-809.DOI:10.1056/NEJMoa1910555.
• [12] Park DW, Park SJ. Unplanned coronary intervention after tavr:timing, causes, and management[J]. JACC Cardiovasc Interv,2021,14(2):208-210. DOI:10.1016/j.jcin.2020.11.021.
• [13] Ricottini E, Nusca A, Ussia GP, et al. Antithrombotic treatment for valve prostheses:which drug, which dose, and when?[J].Prog Cardiovasc Dis,2022,72:4-14. DOI:10.1016/j.pcad.2022.05.008.
• [14]秦泽家.数智时代环境下情报协同驱动全生命周期健康服务体系构建研究[J].情报理论与实践，2024,47(1):65-74.DOI:10.16353/j.cnki.1000-7490.2024.01.009.
• [15] Allen LA, Venechuk G, McIlvennan CK, et al. An electronically delivered patient-activation tool for intensification of medications for chronic heart failure with reduced ejection fraction:the EPIC-HF trial[J]. Circulation,2021,143(5):427-437. DOI:10.1161/CIRCULATIONAHA.120.051863.
• [16] Lachonius M, Wallstr?m S, Odell A, et al. Patients'motivation to undergo transcatheter aortic valve replacement. A phenomenological hermeneutic study[J]. Int J Older People Nurs,2023,18(1):e12521. DOI:10.1111/opn.12521.
• [17]杨莹，熊晓云，魏雯婷，等.经皮冠状动脉介入治疗术后患者运动康复依从性的研究进展[J].军事护理，2023,40(11):19-22.DOI:10.3969/j.issn.2097-1826.2023.11.005
• [18] Mentias A, Desai MY, Saad M, et al. Incidence and outcomes of acute coronary syndrome after transcatheter aortic valve replacement[J]. JACC Cardiovasc Interv,2020,13(8):938-950. DOI:10.1016/j.jcin.2019.11.027.
• [19] Winter JL, Healey JS, Sheth TN, et al. Remote ambulatory cardiac monitoring before and after transcatheter aortic valve replacement[J]. CJC Open,2020,2(5):416-419. DOI:10.1016/j.cjco.2020.04.006.
• [20] Mukhopadhyay A,Reynolds HR,Xia Y,et al. Design and pilot implementation for the BETTER CARE-HF trial:a pragmatic cluster-randomized controlled trial comparing two targeted approaches to ambulatory clinical decision support for cardiologists[J]. Am Heart J,2023,258:38-48. DOI:10.1016/j.ahj.2022.12.016.